Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease

Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease

There is a great concern in the literature for the development of neuroprotectant drugs to treat Parkinson's disease. Since anesthetic drugs have hyperpolarizing properties, they can possibly act as neuroprotectants. In the present study, we have investigated the neuroprotective effect of a mix...

Full description

Bibliographic Details
Main Authors:	M.M. Ferro, M.E.M. Angelucci, J.A. Anselmo-Franci, N.S. Canteras, C. Da Cunha
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2007-01-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Neuroprotection 6-Hydroxydopamine 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine Ketamine Parkinson's disease
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000100012

Similar Items

Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
by: Seulah Lee, et al.
Published: (2021-02-01)

Animal Models for Parkinson’s Disease Research: Trends in the 2000s
by: Kyohei Kin, et al.
Published: (2019-10-01)

Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency
by: Hao Wu, et al.
Published: (2021-03-01)

Análise histomorfométrica do músculo sóleo de ratos submetidos ao modelo animal de parkinsonismo induzido pelo MPTP
by: Ana Paula Cunha Loureiro, et al.

Relationship Between the Anxious Symptoms and the Neurotransmitter in Parkinson's Mice with Different Dosages of MPTP
by: Yu Xia, et al.
Published: (2018-11-01)

Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease
by: Michael D. Boska, et al.
Published: (2007-06-01)

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
by: Bruce Do Van, et al.
Published: (2016-10-01)

Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model
by: Ye Lee Jun, et al.
Published: (2015-04-01)

Comparative analysis of dose-dependent neurotoxic response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 N mice derived from three different sources
by: Dong-Joo Hwang, et al.
Published: (2019-07-01)

Mitochondrial E3 Ubiquitin Ligase Parkin: Relationships with Other Causal Proteins in Familial Parkinson’s Disease and Its Substrate-Involved Mouse Experimental Models
by: Satoru Torii, et al.
Published: (2020-02-01)

Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism
by: Elena A. Kozina, et al.
Published: (2017-02-01)

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons
by: Haruhiko Kishima, et al.
Published: (2004-07-01)

Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration
by: Dong-Young Choi, et al.
Published: (2013-01-01)

LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP
by: Yang Tan, et al.
Published: (2020-02-01)

Mitigation Effects of a Novel Herbal Medicine, Hepad, on Neuroinflammation, Neuroapoptosis, and Neuro-Oxidation
by: Da Hye Song, et al.
Published: (2018-11-01)

Neuroprotective Effects of a Traditional Multi-Herbal Medicine Kyung-Ok-Ko in an Animal Model of Parkinson's Disease: Inhibition of MAPKs and NF-κB Pathways and Activation of Keap1-Nrf2 Pathway
by: Jong Hee Choi, et al.
Published: (2018-12-01)

Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
by: Jong Hee Choi, et al.
Published: (2018-05-01)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
by: Wang Qingshan, et al.
Published: (2012-06-01)

Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate
by: A. Moran, et al.
Published: (2012-01-01)

Biomechanical Assessment of Normal and Parkinsonian Gait in the Non-human Primate During Treadmill Locomotion
by: Thota, Anil K.
Published: (2012)

Date preliminare privind unele manifestări ale durerii într-un model de șobolan MPTP-indus a bolii Parkinson
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease
by: Ken Kuwahara, et al.
Published: (2020-06-01)

A study of the neurotoxicity of MPTP and analogs in human neuroblastoma SH-SY5Y cells
by: Song, Xiaoou
Published: (2014)

Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
by: Carbone Marica, et al.
Published: (2012-04-01)

An in vitro study on astrocytic glutathione metabolism after MPTP treatment.
Published: (1995)

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
by: Isabel Lastres-Becker, et al.
Published: (2005-06-01)

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
by: Elisabetta Polazzi, et al.
Published: (2012-05-01)

An in vitro study on astrocytic nitric oxide production after MPTP treatment.
Published: (1997)

In vivo and in vitro studies on the role of metallothionein in MPTP/MPP⁺-induced neurotoxicity.
Published: (2000)

Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model
by: Hyunjun Park, et al.
Published: (2020-10-01)

Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models
by: Tao Lu, et al.
Published: (2017-01-01)

Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice
by: Javad Hami, et al.
Published: (2016-01-01)

Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss
by: A.L. Spieles-Engemann, et al.
Published: (2010-07-01)

Ketamine: Neuroprotective or Neurotoxic?
by: Divya Choudhury, et al.
Published: (2021-09-01)

An Examination of mobile spinal cord stimulators on treating Parkinson disease
by: Zhen-Jie Wang, et al.
Published: (2021-01-01)

Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson’s Disease
by: Shih-Chang Hsueh, et al.
Published: (2018-02-01)

Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease
by: Erzsebet Kokovay, et al.
Published: (2005-08-01)

Astragalus protects PC12 cells from 6-hydroxydopamine-induced neuronal damage: A serum pharmacological study
by: Li-Ying Guo, et al.
Published: (2021-01-01)

Neuroprotective potential of quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
by: Shamsher Singh, et al.
Published: (2017-01-01)

Neuroprotective effect of quercetin in a model of Parkinson’s disease in rat: A histochemical analysis
by: Mehdi Mehdizadeh, et al.
Published: (2009-01-01)

Cannot write session to /tmp/vufind_sessions/sess_d2iif626d5ot93qp7svesnufcv